SARS-CoV-2 persistence in immunocompromised children.
Susan A DolanJean M Mulcahy LevyAngela MossKelly PearceMolly ButlerSarah JungSamuel R DominguezEric MwangiKelly MaloneySuchitra RaoPublished in: Pediatric blood & cancer (2021)
Most ICC with SARS-CoV-2 infection had mild disease, with prolonged viral persistence >6 weeks and moderate to high viral load.